Clinical Guidelines

July 24, 2026

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

A panel of ASCO experts voted to approve ASCO’s first guideline on ctDNA testing in patients with solid tumors or lymphoma on November 18, 2025.1 The guideline addresses four overarching clinical ques...

The ASCO Post

July 24, 2026

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

The ASCO Post

July 23, 2026

FDA Approves Zidesamtinib for Second-Line Treatment of ROS1-Positive NSCLC

The ROS1 selective inhibitor was approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer (NSCLC) who received a prior ROS1 kinase inhi...

The ASCO Post

July 23, 2026

FDA Approves Zidesamtinib for Second-Line Treatment of ROS1-Positive NSCLC

The ASCO Post

July 21, 2026

Emergency Department Cancer Diagnosis Associated With Higher Mortality Across 16 Cancer Types

Diagnosis of a cancer upon emergency department presentation was associated with an elevated mortality rate, which was consistent across 16 analyzed cancer types, according to new research findings pu...

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

July 21, 2026

AMP Recognizes NCI Pathologist With Award for Excellence in Molecular Diagnostics

Her research has revealed the molecular underpinnings of T-cell, B-cell, and natural killer–cell lymphomas, and her insights into Epstein–Barr virus–associated disorders, Castleman disease, and immune...

The ASCO Post

July 20, 2026

National Survey Links Civic Engagement to Higher Breast Cancer Screening Rates

Findings from a National Health Interview Survey revealed that civically engaged adults were more likely to stay up to date with their breast cancer screenings. The research findings were published in...

The ASCO Post

July 20, 2026

Oral Nicotinamide May Offer Cost-Effective Prevention of Keratinocyte Carcinoma

Oral nicotinamide may provide a cost-effective strategy for preventing keratinocyte carcinoma (KC) in persons at high risk, according to a study published in JAMA Dermatology. Led by David Perez, BA, ...

The ASCO Post

July 17, 2026

Meta-Analysis Highlights Cardiovascular Safety Advantage of Second-Generation BTK Inhibitors

In a meta-analysis published in The Oncologist, researchers found that second-generation Bruton's tyrosine kinase (BTK) inhibitors had a better cardiovascular safety profile than the first-generation ...

The ASCO Post

July 16, 2026

Virtual Sustained Counseling and Tobacco Treatment Improve Quit Rates for Patients With Cancer in Community Settings

Virtual sustained counseling and nicotine replacement therapy led to an almost doubling of 6-month smoking quit rates compared with standard care for patients facing a recent cancer diagnosis, accordi...

The ASCO Post

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Clinical Guidelines

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

FDA Approves Zidesamtinib for Second-Line Treatment of ROS1-Positive NSCLC

FDA Approves Zidesamtinib for Second-Line Treatment of ROS1-Positive NSCLC

Emergency Department Cancer Diagnosis Associated With Higher Mortality Across 16 Cancer Types

Daily News

AMP Recognizes NCI Pathologist With Award for Excellence in Molecular Diagnostics

National Survey Links Civic Engagement to Higher Breast Cancer Screening Rates

Oral Nicotinamide May Offer Cost-Effective Prevention of Keratinocyte Carcinoma

Meta-Analysis Highlights Cardiovascular Safety Advantage of Second-Generation BTK Inhibitors

Virtual Sustained Counseling and Tobacco Treatment Improve Quit Rates for Patients With Cancer in Community Settings

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

The Medicine Maker

The Analytical Scientist

Clinical Guidelines

Daily News

Recommendations